Makale
When worlds converge: How Most-Favored-Nation policy and International Reference Pricing reshape global market access interdependencies
-
Erika Wissinger
-
David Ringger, PHD
-
Casper Paardekooper
-
Diane Smith
This article was originally published on ISPOR
Global drug pricing decisions do not happen in isolation
This article explores how most favored nation policies and international reference pricing are reshaping global market access by linking pricing, reimbursement, and launch decisions across markets. It highlights why manufacturers need a more coordinated strategy to anticipate downstream effects on pricing, access, and commercialization.
Click below to read the full article today.
Click below to read the full article today.
